Articles On Genetic Technologies (ASX:GTG)

Title Source Codes Date
Closing Bell: Markets are in revolution and the ASX just stormed its psychological Bastille

ASX 200 punches through 8,000 on Monday All sectors higher Small cap miners led by Aldoro Resources Local markets surged into record territory on Monday, pushing through the 8,000 threshold as traders played catch up to Wall Street’s r...

Stockhead GTG 4 days ago
ASX Health June Winners: Actinogen and Optiscan led a sector in good shape

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

Stockhead GTG 2 weeks ago
Genetic Technologies say geneType tests identify 79.5% of people with elevated risk of disease

Genomics-based testing producer Genetic Technologies Ltd (ASX:GTG) believes its geneType Risk Assessment tests – sold in Australia and the United States – have the potential to clearly identify people with serious risk of disease or cancer,...

themarketonline.com.au GTG 3 weeks ago
Closing Bell: A very hot ASX banks on big banks after big central banks start cutting

Aussie shares rally Rate sensitive stocks gain, led by Tech FTL soars on Newfoundland deal   Aussie shares climbed strongly on Thursday closing above 7,820 as major global central banks began to cut interest rates and in the US, the S&amp...

Stockhead GTG 1 month ago
Top 10 at 11: This morning is all about techies and goldies and bears, oh my!

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead GTG 1 month ago
ASX Health Winners in May: LTR Pharma leads, and why hopes are high for biotech stocks this year

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Stockhead GTG 1 month ago
Closing Bell: Miners, Energy stocks sink ASX; Nanovue up 60pc on EyeFly3D deal

ASX down by -0.5pc, weekly loss surpasses 2pc Mining, Energy stocks main laggards today Asian stocks also decline, North Korea fires ballistic missiles   The ASX200 index has dipped lower by -0.5% on Thursday, taking its weekly loss to mo...

Stockhead GTG 1 month ago
ASX Health Stocks: Cleo up 30pc and GTG up 13pc after cancer test kit progress

Cleo jumps 30pc after publishing study results Cleo Diagnostics (ASX:COV) surged nearly 30% this morning after announcing a breakthrough article on its blood test for early ovarian cancer detection. The article, entitled ‘Utility of a Multi...

Stockhead GTG 1 month ago
Top 10 at 10: REE-nergised rare earths explorers, biotech standouts lead Wednesday’s winners

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 1 month ago
Check Up: Alzheimer’s is ‘preventable’, so here’s what you must do; and recent ASX biotech winners

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

Stockhead GTG 1 month ago
ASX Health Winners April: Mesoblast leads; and why the Health sector is just built different

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

Stockhead GTG 2 months ago
Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

Stockhead GTG 2 months ago
Top 10 at 10: Here comes this project’s first gold drilling program in over a decade

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 3 months ago
Genetic Technologies kicks off US breast cancer imaging campaign

Dual ASX and NASDAQ smallcap Genetic Technologies (ASX:GTG) has announced its launch of a breast cancer imaging program across three US clinics in NY, Miami and Houston, Texas. The program will integrate GTG’s “geneType” saliva-based and...

themarketonline.com.au GTG 3 months ago
Market Update: ASX takes a breather from lofty peaks

The ASX200 is down nearly half a per cent – beating futures predictions. Aside from health care and real estate, most sectors have been in the red so far. In this bulletin, we’ll look at news from Fisher & Paykel Healthcare Corpor...

themarketonline.com.au GTG 3 months ago
Genetic Technologies unveils revolutionary cancer detection test

Genetic Technologies (ASX:GTG), known for its expertise in genomics-based testing, has introduced its most advanced risk assessment test for serious diseases – including breast and ovarian cancer. This new test builds upon the success of it...

themarketonline.com.au GTG 3 months ago
Genetic Technologies unveils GeneType test for unprecedented disease risk assessment

Molecular diagnostics company Genetic Technologies (ASX: GTG) has announced a major breakthrough in risk assessment tests for serious diseases. The new GeneType technology builds on the success of the company’s comprehensive hereditary brea...

smallcapsau.mystagingwebsite.com GTG 3 months ago
ASX Health Winners February: Law of attrition applies but biotech is a long term game; Nyrada up 5x last month

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

Stockhead GTG 4 months ago
Top 10 at 11: Half year results and legal woes are making news today

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead GTG 4 months ago
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Stockhead GTG 4 months ago
Top 10 at 10: Special EV loans, M&A, and a big Brazil REE buy

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead GTG 7 months ago
10 at 11ish: Aurumin to sell iron rights to Mineral Resources

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

Stockhead GTG 7 months ago
Closing Bell: The ASX is slightly higher, but not much cooler on Monday

The ASX benchmark has closed slightly higher on Monday Energy Sector gains after oil prices rose over the weekend Small caps led Killi Resources, Nyrada and Viridis Mining   The Aussie sharemarket has ended the opening salvo of the week...

Stockhead GTG 7 months ago
Closing Bell: ASX ends it like Beckham… lower and with a pretty whimper, which could still suggest good things ahead

The ASX benchmark has closed slightly lower on Friday Losses across the Energy Sector weighed Small caps led ID8   The Aussie sharemarket has ended lower on Friday, driven to a small disgrace by the ongoing declines in oil prices – down...

Stockhead GTG 8 months ago
Top 10 at 11: Buy-ups, Buy-outs and Payouts are what’s moving the market this morning

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

Stockhead GTG 8 months ago
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

Stockhead GTG 8 months ago
Closing Bell: Australian stocks go higher, for longer on bets The Fed won’t have to

The ASX has ended Wednesday jumping almost 100 points. Huge effort, everyone Energy Sector misses out on all the positive vibes Small caps led by Findi and Firebrick Pharma   The Australian sharemarket is in fine fettle on this Wednesday...

Stockhead GTG 8 months ago
Closing Bell: Broad-based whinging leads ASX back to the start of 2023, minus the hope and ignorance

The ASX has ended -0.4% lower, just 2.5 points from 2023 parity Utilities only sector in green Small caps led by 4DX, Infinity and a few Lake Johnston lithium plays   The local market is back to digging its little hole from which it may t...

Stockhead GTG 8 months ago
Closing Bell: ASX gains trimmed by deflating Chinese data, however it’s Kristmas at Krakatoa with thick peggies for all

The ASX has closed higher Healthcare leads sector gains Small caps led by KTA and FG1   The Aussie sharemarket has trimmed the fat off this morning’s substantial gains – at one stage there we were easing past the 7,350 mark and off to th...

Stockhead GTG 8 months ago
10 at 11ish: Thick peggies = 73pc pop. Krakatoa cracks the lithium code at King Tamba

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

Stockhead GTG 8 months ago
Closing Bell: Smart and casual, ASX makes it five in a row; next up – rates and horse races

ASX200 closes +0.28% higher Healthcare leads gains, ASX All Gold rises over +3% Small caps led by takeover target Whispir   The Australian sharemarket has ended higher on the first day of what is certain to be another week of intensely tr...

Stockhead GTG 8 months ago
Closing Bell: Even the Aussie dollar appreciates a good lead as dynamic surge makes local IT the it sector for a day

ASX200 closes 0.9pc higher Property stocks and IT sector enjoy huge day Small caps led by DCL   The Australian sharemarket has lifted strongly on Day Two of Trading in November, the Best Month for Trading Ever. Local investors got stuck r...

Stockhead GTG 8 months ago
Closing Bell: It certainly wasn’t cricket as Monday markets in Australia knocked right back to last year

Benchmark ASX index closes at new 12-month lows Energy and Materials the worst of 9 dipping ASX sectors on Monday Small caps led by CHM, TON   On Monday Aussie markets rediscovered their nadir of the year. No real surprises, since every n...

Stockhead GTG 8 months ago
Top 10 at 11: This morning is all about lithium, graphite and the fight against Glioblastoma 

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

Stockhead GTG 8 months ago
Top 10 at 11: Copper, Gold and Lithium are keeping the market’s doors open this morning

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

Stockhead GTG 9 months ago
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

Stockhead GTG 9 months ago
Traders’ Diary: A week of War, Worry and Wall Street earnings

The Week That Was The world looks very different this week after the addition of what Barclays economic team calls ‘a complex cocktail of geopolitical risk, mixed macro data, a nervous oil market,’ and a US Fed finding nice things to say ab...

Stockhead GTG 9 months ago
Closing Bell: Noxopharm ignores screams as unsuspecting local markets ambushed by hellish bank-tech-comms beastie

Benchmark index falls to 11-month lows Utilities only sector in green Small caps led by Noxopharm   Local markets have extended unexpected October losses on Wednesday as tech stocks, and the Financial Sector led losses on another bond-...

Stockhead GTG 9 months ago
Closing Bell: Bleak benchmark goes back to the beginning as Wall Street worries widen; RBA holds at 4.1pc

ASX200 drops sharply on Wall Street worry Healthcare only sector to rise Small caps led by Noxopharm, Nimy Resources, Alderan and ECS Botanics   The ASX200 has inched below where it was at the start of 2023, while the Australian dollar...

Stockhead GTG 9 months ago
Closing Bell: ASX trips at starting gun while US Futures jump on world not ending yet

Benchmark index falls on Monday, closing out the day down 0.21% Utilities and Materials sectors edge higher, but Health Care anchors the benchmark into the red Small caps led by Galileo Mining, Infinity and last week’s rockstar Biotron...

Stockhead GTG 9 months ago
Hot Money Monday: These are the top momentum stocks; and introducing the Simple Moving Average

We look at which ASX stocks are trading on a momentum 52-week high and RSI are two indicators of momentum Simple Moving Average is also another measure of momentum   Last week, we looked at how traders find stocks that are trading with mo...

Stockhead GTG 9 months ago
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Stockhead GTG 9 months ago
Closing Bell: Local markets fall on timid Tuesday but Biotron bets build as investors ask if it’s aced an anti-viral AIDS therapy

Benchmark index settles almost -0.6% lower on Tuesday All sectors bar Healthcare and Financials in the red Small caps led by NickelSearch and Biotron A positive lead from Wall Street overnight didn’t sell well on local markets, which were...

Stockhead GTG 9 months ago
Top 10 at 11: Uranium price surge offers a healthy glow to an otherwise weird market

Stockhead’s Top 10 at shortly-before-11-ish, published through a haze of that horrible “I’m awake and doing stuff but my heart’s still asleep” feeling that I’ve decided to blame on the post-50-years-old blues, and not on the recent launch o...

Stockhead GTG 9 months ago
Closing Bell: Local markets shed 0.6pc as we brace for tonight’s US Fed call

The ASX 200 benchmark falls 0.6% as we brace for news from The Fed Sector losses led by Resources, while Consumers make gains Small caps led by Alderan, and BNPL Sezzle returns   Local markets made it a hat trick of losses, with the re...

Stockhead GTG 9 months ago
ASX cancer stocks guide: Here’s everything you need to know

According to the World Health Organisation (WHO), cancer is the leading cause of death globally. WHO defines cancer as a generic term for a large group of diseases that can affect any part of the body with malignant tumours and neoplasms. W...

Stockhead GTG 10 months ago
Closing Bell: A lean green Friday on the screen as ASX climbs 1.3%, rides upbeat economic vibes

ASX 200 closes 1.3% higher, adds 1.5% for the week All Sectors in the green following strong Chinese data drop Small caps led by OZM, uranium stocks   Australian shares have risen strongly on Friday following decent overnight leads from...

Stockhead GTG 10 months ago
Closing Bell: Resources to the ASX rescue, but it’s uranium that’s gone nuclear

ASX 200 closes 0.46% higher after building up slowly all day Uranium goes off. Materials, Finance Sectors call the shots Small caps led by an all uranium cast, including   Australian shares have been lifted despite a mixed overnight lea...

Stockhead GTG 10 months ago
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Stockhead GTG 10 months ago
Top 10 at 11: This morning’s early gains are brought to you by lithium, nickel and… almonds.

Stockhead’s Top 10 at shortly-before-11-ish, published shortly after I’ve located my reading glasses and wiped the bacon grease off my fingers at the start of each trading day. It highlights the best (and sometimes worst) performing ASX sto...

Stockhead GTG 10 months ago